Rostislav Christov Raykov Sells 16,667 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock

Fennec Pharmaceuticals Inc. (TSE:FRX) Director Rostislav Christov Raykov sold 16,667 shares of Fennec Pharmaceuticals stock in a transaction that occurred on Friday, May 16th. The shares were sold at an average price of C$9.49, for a total transaction of C$158,203.16.

Rostislav Christov Raykov also recently made the following trade(s):

• On Friday, April 4th, Rostislav Christov Raykov sold 10,000 shares of Fennec Pharmaceuticals stock. The shares were sold at an average price of C$7.46, for a total value of C$74,550.00.
• On Wednesday, March 5th, Rostislav Christov Raykov sold 7,569 shares of Fennec Pharmaceuticals stock. The shares were sold at an average price of C$9.71, for a total transaction of C$73,503.54.

Fennec Pharmaceuticals Stock Up 19.4%

FRX stock opened at C$11.34 on Wednesday. The firm has a market capitalization of C$218.69 million, a price-to-earnings ratio of -192.10 and a beta of 0.25. The company has a debt-to-equity ratio of -620.83, a quick ratio of 10.17 and a current ratio of 7.80. The company’s 50 day moving average price is C$8.30 and its 200 day moving average price is C$8.46. Fennec Pharmaceuticals Inc. has a fifty-two week low of C$5.65 and a fifty-two week high of C$11.49.

About Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.